Capital Stock Transactions

12 Months Ended

Jun. 30, 2023

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Stock Option Plans

As of June 30, 2023, the Company had in effect two employee stock option plans that provide for incentive and non-qualified stock options. Under the terms of the plans, options may not be granted for less than the fair market value of the Common Stock at the date of grant. Vesting generally occurs ratably between one and five years and for non-employee directors, immediately, and the options are exercisable over a period no longer than 10 years after the grant date. As of June 30, 2023, options to purchase 157,000 shares of the Company’s common stock were outstanding and exercisable.

The following is a summary of Escalon’s stock option activity and related information for the fiscal years ended June 30, 2023 and 2022:

	2023			2022
	Common Stock Options	Weighted Average Exercise Price		Common Stock Options	Weighted Average Exercise Price
Outstanding at the beginning of the year	157,000	$	1.47	157,000	$	1.47
Granted	—	—		—	—
Exercised	—	—		—	—
Forfeited	—	—		—	$	—
Outstanding at the end of the year	157,000	$	1.47	157,000	$	1.47
Exercisable at the end of the year	157,000	$	1.47	157,000	1.47

The following table summarizes information about stock options outstanding as of June 30, 2023:

	Number Outstanding at June 30, 2023	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price		Number Exercisable at June 30, 2023	Weighted Average Exercise Price
Range of Exercise Prices
$0.79	21,000	2.83	$	0.79	21,000	$	0.79
$1.45 to $2.12	136,000	0.83	$	1.57	136,000	$	1.57
Total	157,000				157,000

There was no compensation expense related to stock options for the years ended June 30, 2023 and 2022.